Russell Frank Company’s MacroGenics MGNX Stock Holding History

Russell Frank Company’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-51,623	Closed	-$1.62M	–	3063
2015 Q1	$1.62M	Sell	51,623 -14,627	-22%	-$496K	﹤0.01%	1898
2014 Q4	$2.32M	Buy	+66,250	New	+$1.65M	﹤0.01%	1695
2014 Q2	–	Sell	-20,242	Closed	-$412K	–	2818
2014 Q1	$412K	Buy	+20,242	New	+$715K	﹤0.01%	2432

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Russell Frank Company's MGNX Position: Q2 2015 in Review

Russell Frank Company sold out of MacroGenics (MGNX) in Q2 2015, closing a stake of 51,623 shares — an estimated $1.62M sold.

Russell Frank Company first reported a position in MGNX in Q1 2014 and held it in 3 quarters. The position peaked at $2.32M in Q4 2014. 128 funds tracked by Wall St. Rank hold MGNX as of Q2 2015.

Russell Frank Company reported no remaining MacroGenics position as of Q2 2015 after selling out during the quarter.
Russell Frank Company sold 51,623 MacroGenics shares in Q2 2015, an estimated $1.62M.
Russell Frank Company first reported a position in MacroGenics in Q1 2014 and held it in 3 quarters.
Russell Frank Company's MacroGenics position peaked at $2.32M in Q4 2014.
128 funds tracked by Wall St. Rank held MacroGenics as of Q2 2015.

Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.